Home » News » Approved Sickle Cell Drug Fails to Beat Placebo in Trial

Approved Sickle Cell Drug Fails to Beat Placebo in Trial

Approved Sickle Cell Drug Fails to Beat Placebo in Trial
May Be Interested In:Migration cuts are a luxury the UK cannot afford



(MedPage Today) — Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
Adjusted annualized rate of vaso-occlusive crises leading to healthcare visits was 2.49 with the standard…

share Share facebook pinterest whatsapp x print

Similar Content

Three wanted in Toronto pub shooting that injured 12
Three wanted in Toronto pub shooting that injured 12 March 8, 2025
Gas giants could be forced to divert supply to Australia
Gas giants could be forced to divert supply to Australia March 24, 2025
Major power outage brings Spain and Portugal to a standstill
Major power outage brings Spain and Portugal to a standstill April 28, 2025
Dem Infighting Continues As Sen Slotkin Blasts AOC, Bernie and Jasmine: ‘What Have They Actually Done?’
Dem Infighting Continues As Sen Slotkin Blasts AOC, Bernie and Jasmine: ‘What Have They Actually Done?’ March 21, 2025
Apple’s Quarterly Earnings Tops Wall Street Expectations With $24.78 Billion Profit
Apple’s Quarterly Earnings Tops Wall Street Expectations With $24.78 Billion Profit May 1, 2025
Finelo 1
How to Conquer Financial Strain in 2025: Finelo and Financial Literacy March 25, 2025
▲
Breaking Barriers: The Stories that Move Us | © 2025 | Daily News